The applicant will work in the Radiology-Unit of the Candiolo Cancer Institute as a Radiologist and will be in charge of the ongoing prospective clinical trial on prostate MRI, including also the enrollment of screening patients. The applicant will also provide support in the development of artificial intelligence systems to detect and characterize prostate cancer lesions. In addition, support to assess quality of MRI examinations and to segment prostate lesions on MRI should be provided during the project.

The research contract will have a duration of 2 years and will be funded by the “ProCancer-I” European Project (reference “952159” – from the call Nº H2020-SC1-FA-DTS-2019-1), granted by the European Union’s Horizon 2020 research and innovation programme.

Qualification and expertise  

The applicant must be qualified as a consultant in Radiology with a minimum of 3 years of experience in the field of multiparametric prostate MRI. The applicant must have substantial skills in both clinical aspects and research within the field of prostate imaging. However, a broad and substantial competence in all aspects of the different radiological procedures is desired, in particular body CT and body MRI.

Applicant should have good knowledge of English language and knowledge of the Italian language or availability to learn the language within 6 months from taking the job at the Candiolo Cancer Institute.

Obligations: The consultant’s obligations are to participate in the clinical duties of the unit on equal terms with the other consultants. Regarding clinical matters, economic issues and management the consultant refers to the chief consultant of the radiology unit.

Application must include the following: 

  • A short letter in which the reasons for application, personal motivation and expectations for the post are explained;
  • Curriculum vitae including personal data, i.e. name, age, master’s degree if any, PhD if any, academic recognitions, awards and prizes, clinical education, previous clinical and scientific positions, publication metrics (Hirsch factor, total number of peer review publications, number of publications during the past five years, as first or last author), editorial work, research supervision, management and financing, teaching experience, number of invited lectures and roles in scientific societies, description of intellectual property if any.
  • List of publications
  • List of meetings attended as an invited speaker
  • Full text of up to 5 publications relevant to the offered position.

 Context

Candiolo Cancer Institute is a private non-profit Institute founded and supported by the Fondazione Piemontese per la Ricerca sul Cancro (FPRC) and the Regione Piemonte and operated by the Fondazione del Piemonte per l’Oncologia. It is the only comprehensive cancer center in the Piedmont Region and is a recognized IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) by the Italian Ministry of Health). The mission of the Institute is to make a significant contribution to fight cancer by understanding the basics and by providing optimal diagnostics and therapeutic services. The interaction between experimental and clinical expertise allows constant transfer of biological models into the clinics. The Radiology unit has approximately 30 full-time positions including 8 staff specialists and 8 doctors in training. The Unit is fully dedicated to oncologic imaging and interventional oncology and, other than prostate imaging and intervention, is equipped with the following equipment: CT, MRI, ultrasound, convention X ray, interventional radiology suite.

Highlights

European Cancer Imaging Initiative launch event

European Cancer Imaging Initiative launch event

The Commission is organising a hybrid event on 23 January 2023 in Brussels to mark the launch of the Cancer Imaging Initiative, one of the Flagship Initiatives of the Europe’s Beating Cancer Plan. This 2.5-hour event will present the policy background and the Cancer...

ProCAncer-I at the RSNA 2022 in Chicago

ProCAncer-I at the RSNA 2022 in Chicago

Our Scientific Manager, Dr Nickolas Papanikolaou was at the 108th Scientific Assembly and Annual meeting (Chicago 27-30/11/2022). The panel discussion included Dr Mona Flores, Global Head of Medical AI at NVIDIA, and Dr Nikos Papanikolaou, Computational Clinical...

ProCAncer-I is proud to be part of the European Federation for Cancer Images (#EUCAIM) project and the European Cancer Imaging Initiative!
Read more about EUCAIM and the Initiative here 👉 https://bit.ly/3XLMT7s
#euCancerImaging #HorizonEU #EU_HEALTH
#EUCancerPlan @eHealth_EU

📢 Job Opportunity!
The @qtimlab is currently looking for a Postdoctoral Research Fellow in medical image analysis with deep learning.
Read more here 👉 https://www.procancer-i.eu/job-openings
#jobalert #jobopening #ClinicalReasearch #sciencecareers #careers #H2020 #HorizonEU #EU_HEALTH

The #EUCAIM project originates from the work and expertise of the AI for Health Imaging Network (AI4HI), composed of INCISIVE, @chaimeleon_eu, @EuCanImage, @ProCAncer_I and @primage_project. #EUCancerImaging #DigitalEU #EUCancerPlan https://digital-strategy.ec.europa.eu/en/policies/cancer-imaging

Proud to be part of the #EUCAIM project led by @EIBIR_biomed, supporting the #EUCancerImaging Initiative by contributing to an infrastructure of Cancer #images and development & benchmarking of AI tools with #EuroBioImaging Nodes & many other partners.
https://www.eurobioimaging.eu/news/proud-to-be-part-of-the-eucaim-project-/

The launch of #EUCancerImaging Initiative will boost innovative cancer diagnostics and treatment and make screening more precise and accessible.

It shows the potential of digital solutions that can bring hope to cancer patients and their families.

#EUCancerPlan

Load More...

Stay in touch!